Skip to main content
Livermore
Livermore
ZHEN

Hancock Whitney Corp

SEC CIK
0000750577
Latest filing
Aug 14, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Hancock Whitney Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
205,652
Value
$16.1M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of HALO by Hancock Whitney Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026205,652$16.1M0.3%−27,890−11.9%ReducedHolders
Q1 2026233,542$14.9M0.3%−8,923−3.7%ReducedHolders
Q4 2025242,465$16.3M0.3%−3,756−1.5%ReducedHolders
Q3 2025246,221$18.1M0.3%+10,326+4.4%AddedHolders
Q2 2025235,895$12.3M0.2%+32,077+15.7%AddedHolders
Q1 2025203,818$13.0M0.4%+83,007+68.7%AddedHolders
Q4 2024120,811$5.78M0.2%+104,015+619.3%AddedHolders
Q3 202416,796$961.4K<0.1%+80+0.5%AddedHolders
Q2 202416,716$875.3K<0.1%+11,286+207.8%AddedHolders
Q1 20245,430$220.9K<0.1%−439−7.5%ReducedHolders
Q4 20235,869$216.9K<0.1%−8−0.1%ReducedHolders
Q3 20235,877$224.5K<0.1%−207−3.4%ReducedHolders
Q2 20236,084$219.0K<0.1%−2,345−27.8%ReducedHolders
Q1 20238,429$322.0K<0.1%−1,148−12.0%ReducedHolders
Q4 20229,577$545.0K<0.1%−20−0.2%ReducedHolders
Q3 20229,597$379.0K<0.1%+386+4.2%AddedHolders
Q2 20229,211$405.0K<0.1%−670−6.8%ReducedHolders
Q1 20229,881$394.0K<0.1%+128+1.3%AddedHolders
Q4 20219,753$392.0K<0.1%−67−0.7%ReducedHolders
Q3 20219,820$399.0K<0.1%−300−3.0%ReducedHolders
Q2 202110,120$460.0K<0.1%−14,578−59.0%ReducedHolders
Q1 202124,698$1.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.